Tabla 2: Estudios de laboratorio al inicio de la hipotermia terapéutica, según la modalidad. |
||||
|
Hipotermia corporal total (n = 8) |
Enfriamiento craneal selectivo (n = 4) |
||
|
Mediana |
mín-máx |
Mediana |
mín-máx |
pH sérico |
7.01 |
6.87-7.15 |
6.96 |
6.99-7.15 |
pO2 (mmHg) |
52.1 |
16.2-172.0 |
78.0 |
23-225.0 |
pCO2 (mmHg) |
34.0 |
18.2-86.10 |
42.90 |
38.6-94.0 |
HCO3 (mmHg) |
19.1 |
3.4-15.10 |
11.60 |
7-17.70 |
Déficit base |
-19.9 |
-26.8, -15.90 |
-17.10 |
-23.2, -13.0 |
Lactato sérico |
12.8 |
11-20.00 |
12.40 |
11.9-16.0 |
% Sat O2 |
84.1 |
12.8-99.0 |
90.80 |
26.3-99.50 |
Hb (g/dL) |
15.4 |
2.9-18.5 |
17.7 |
16-20.1 |
Na (mmol/L) |
130.5 |
120-137.0 |
126.0 |
119-133.0 |
Cloro (mmol/L) |
106.0 |
99-109.0 |
103.0 |
97-111.0 |
Glucosa (g/dL) |
57.0 |
6-148.0 |
99.0 |
18-131.0 |
CPK (mg/dL) |
346.0 |
138-2,970.0 |
849.0 |
357-1,582.0 |
CPK BB |
10.8 |
4.1-22.7 |
10.0 |
2.3-22.0 |
CPK MB |
4.6 |
0-11.1 |
5.0 |
3-5.0 |
Dímero D (μg/L) |
5,744.0 |
0-39,162.0 |
1,217.0 |
825-42,924.0 |
Fibrinógeno (mg/dL) |
95.2 |
0-164.0 |
117.2 |
55.5-192.3 |